MYX mayne pharma group limited

News: MYX Mayne Pharma Group Says H1 Revenue From Ordinary Activities $227.2 Mln, Down 17.2%

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Feb 21 (Reuters) - Mayne Pharma Group Ltd (MYX) :

    • H1 REVENUE FROM ORDINARY ACTIVITIES $227.2 MILLION, DOWN 17.2%
    • HY LOSS FROM ORDINARY ACTIVITIES ATTRIBUTABLE $17.5 MILLION VERSUS PROFIT OF $2.6 MILLION

    Source text https://reut.rs/2vMKK37

    (([email protected];))

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.98
Change
0.030(0.61%)
Mkt cap ! $402.1M
Open High Low Value Volume
$4.97 $4.98 $4.97 $43.03K 8.659K

Buyers (Bids)

No. Vol. Price($)
2 14 $4.98
 

Sellers (Offers)

Price($) Vol. No.
$4.99 1200 1
View Market Depth
Last trade - 10.00am 01/08/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.